BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25303400)

  • 1. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes.
    Tseng CH
    Ann Med; 2013 Dec; 45(8):539-44. PubMed ID: 24215589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with human insulin does not increase thyroid cancer risk in patients with type 2 diabetes.
    Tseng CH
    Eur J Clin Invest; 2014 Aug; 44(8):736-42. PubMed ID: 24931333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan.
    Tseng CH
    Gynecol Oncol; 2013 Oct; 131(1):135-9. PubMed ID: 23877016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human insulin does not increase bladder cancer risk.
    Tseng CH
    PLoS One; 2014; 9(1):e86517. PubMed ID: 24466131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human insulin does not increase prostate cancer risk in Taiwanese.
    Tseng CH
    Clin Genitourin Cancer; 2014 Feb; 12(1):e7-12. PubMed ID: 24121018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):18802-18810. PubMed ID: 27861146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea.
    Cho YY; Kang MJ; Kim SK; Jung JH; Hahm JR; Kim TH; Nam JY; Lee BW; Lee YH; Chung JH; Song SO; Kim SW
    Thyroid; 2018 Jul; 28(7):864-870. PubMed ID: 29808777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.